. "Adam, Zden\u011Bk" . "\u0160estilet\u00E9 sledov\u00E1n\u00ED pacienta s mnoho\u010Detnou angiomat\u00F3zou postihuj\u00EDc\u00ED skelet, b\u0159i\u0161n\u00ED i hrudn\u00ED dutinu a st\u011Bnu tr\u00E1vic\u00ED trubice"@cs . "25" . "RIV/00209805:_____/12:#0000393" . . . "Thalidomid 100 mg/den stabilizoval mnoho\u010Detnou angiomat\u00F3zu l\u00E9pe ne\u017E interferon alfa. Thalidomid 50 mg/den ji\u017E neudr\u017Eel stabilitu nemoci. Lenalidomid v d\u00E1vce 10 mg byl excelentn\u011B tolerov\u00E1n, ale tato d\u00E1vka nedosta\u010Dovala pro udr\u017Een\u00ED stabiln\u011B n\u00EDzk\u00FDch hodnot D-dimer\u016F a norm\u00E1ln\u00ED koncentrace hemoglobinu. Kombinace lenalidomidu v d\u00E1vce 10 mg a thalidomidu v d\u00E1vce 50 mg stabilizovala stav po dobu 9 m\u011Bs\u00EDc\u016F. P\u0159i pou\u017Eit\u00ED thalidomidu a lenalidomidu se s\u010D\u00EDt\u00E1 antiangiogenn\u00ED \u00FA\u010Dinek. D\u00EDky odli\u0161nosti ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F obou l\u00E9k\u016F je tolerance t\u00E9to kombinace dobr\u00E1."@cs . . . "[E3866304748E]" . . "Koukalov\u00E1, Renata" . . "Thalidomid 100 mg/den stabilizoval mnoho\u010Detnou angiomat\u00F3zu l\u00E9pe ne\u017E interferon alfa. Thalidomid 50 mg/den ji\u017E neudr\u017Eel stabilitu nemoci. Lenalidomid v d\u00E1vce 10 mg byl excelentn\u011B tolerov\u00E1n, ale tato d\u00E1vka nedosta\u010Dovala pro udr\u017Een\u00ED stabiln\u011B n\u00EDzk\u00FDch hodnot D-dimer\u016F a norm\u00E1ln\u00ED koncentrace hemoglobinu. Kombinace lenalidomidu v d\u00E1vce 10 mg a thalidomidu v d\u00E1vce 50 mg stabilizovala stav po dobu 9 m\u011Bs\u00EDc\u016F. P\u0159i pou\u017Eit\u00ED thalidomidu a lenalidomidu se s\u010D\u00EDt\u00E1 antiangiogenn\u00ED \u00FA\u010Dinek. D\u00EDky odli\u0161nosti ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F obou l\u00E9k\u016F je tolerance t\u00E9to kombinace dobr\u00E1." . . . . "1" . "\u0160estilet\u00E9 sledov\u00E1n\u00ED pacienta s mnoho\u010Detnou angiomat\u00F3zou postihuj\u00EDc\u00ED skelet, b\u0159i\u0161n\u00ED i hrudn\u00ED dutinu a st\u011Bnu tr\u00E1vic\u00ED trubice" . "16"^^ . . . "RIV/00209805:_____/12:#0000393!RIV13-MZ0-00209805" . "167587" . . . . "http://www.linkos.cz/files/klinicka-onkologie/168/3926.pdf" . "18"^^ . "Six-year follow-up of a patient with multiple angiomatosis involving skeleton, thoracic and abdominal cavities and the gut wall"@en . . "Thalidomide in the dose of 100 mg daily led to better stabilisation of the disease than interferon-alpha. However, lowering the dose because of adverse effects failed to be effective sufficiently. Lenalidomide 10 mg daily was well-tolerated but insufficient to improve D-dimer and haemoglobin concentrations. Therefore, for further treatment we have decided to use the combination of lenalidomide and thalidomide in doses of 10 mg and 50 mg, respectively because both drugs have desirable antiangiogenic activities with different adverse effect profiles. On this therapy, the patient\u2019s disease has been stable for 9 months."@en . "\u0160estilet\u00E9 sledov\u00E1n\u00ED pacienta s mnoho\u010Detnou angiomat\u00F3zou postihuj\u00EDc\u00ED skelet, b\u0159i\u0161n\u00ED i hrudn\u00ED dutinu a st\u011Bnu tr\u00E1vic\u00ED trubice" . "I, P(LC06027), P(NS10408), P(NT11154), P(NT12130), P(NT12215), Z(MSM0021622434), Z(MZ0MOU2005)" . . . "0862-495X" . . . . . "\u0158eh\u00E1k, Zden\u011Bk" . "Klinick\u00E1 onkologie" . . "CZ - \u010Cesk\u00E1 republika" . . . . "2"^^ . . "Six-year follow-up of a patient with multiple angiomatosis involving skeleton, thoracic and abdominal cavities and the gut wall"@en . "\u0160estilet\u00E9 sledov\u00E1n\u00ED pacienta s mnoho\u010Detnou angiomat\u00F3zou postihuj\u00EDc\u00ED skelet, b\u0159i\u0161n\u00ED i hrudn\u00ED dutinu a st\u011Bnu tr\u00E1vic\u00ED trubice"@cs . "angiomatosis; zoledronate; thalidomide; interferon alpha; lenalidomide; disseminated intravascular coagulation"@en . .